Baillie Gifford Emerging Markets is aided by a seasoned team and competitive fees.
Alex Bryan shares research and fund-specific suggestions.
What is driving traffic at Mexico's airports?
Franklin Mutual Quest features an experienced team and low fees.
Michael Kitces says retirees could be more flexible with withdrawal rates.
Investors should keep an eye out for high dividend payouts and potential capital gains in these real estate opportunities.
This week on the podcast, how to manage cash in retirement, a healthcare insurance pick, and good funds having a great year.
Returns on invested capital remain depressed, leading to the downgrade.
Fixed-income funds of all stripes did well during the first quarter. Can it continue?
Jon Hale recaps the first quarter for U.S. ESG funds, which continue to build on their record inflows from the previous year.
Expect strong issuance to continue in 2019 for this niche area of the bond market.
At the cost of being vanilla, investors push into low-cost ETFs.
Russ Kinnel breaks down how mutual funds performed during the market rally.
We're raising our fair value estimate for UnitedHealth and think investors should consider this wide-moat firm.
Russ Kinnel discusses how teaming up two complementary mutual funds can help build a well-diversified IRA.
The veteran team behind this Bronze-rated fund sticks with stellar growth companies for the long haul.
Christine Benz looks at how retirees can make the best use of the cash bucket.
These Morningstar Medalists' returns finished near the top of their respective categories last quarter.
This week on the podcast, we look at passive foreign stock funds and Vanguard's LifeStrategy Target Risk Series.
With a credit pullback and larger supply of used vehicles, there likely won't be growth in U.S. auto sales this year.
Risk preference may steer investors toward one fund or the other, but many should consider holding the both American Funds Europacific Growth and FMI International.
Index funds are gaining ground on their active counterparts in this arena.
Bets on sports and news loom large for a firm that's now much smaller after its deal with Disney.
Christine Benz spotlights attractive HSA features to remember before the tax-filing deadline.
This Gold-rated series features low fees and a straightforward portfolio design.
We think these firms will continue to be consistent dividend-payers as the commercial aerospace cycle goes on strong and U.S. defense budgets increase.
This week on the podcast, upgrades among big banks, high-quality mid-cap stocks, and tips for older IRA investors.
We initiate coverage of the Fox Corporation after the Disney merger.
Morningstar's Ali Mogharabi gives his take on the company's value, how it stacks up against Uber, and the threat that regulation poses.
Baird Core Plus Bond stands out for its consistent style, excellent approach to risk management, and strong stewardship.
Industry changes can affect moats and more.
Senior analyst Brian Moriarty explains the performance and shares some favorite ideas.
Bronze-rated Royce Opportunity remains an attractive option despite its volatility.
Christine Benz discusses what older adults should consider when making IRA contributions.
Ariel's John Rogers dicussses why he likes Jones Lang LaSalle and Stericycle.
Christine Benz shares her favorite fixed-income picks for the intermediate-term portion of her ETF bucket portfolios for retirees.
This week on the podcast, finding "fantastic" funds, Vanguard's inflation hedge, and the changing face of value investing.
Ariel's John Rogers explains why stocks with low price/earnings multiples are less resilient than they used to be.
This wide-moat firm is well-positioned and high-quality.
With its low fees, Vanguard Inflation-Protected Securities is a standout in its category.
Russ Kinnel discusses the criteria he uses to compile his annual list of top funds.
Wide-moat firms Kellogg and Campbell Soup each appear attractive, trading at more than 20% discounts to our valuation.
Christine Benz discusses some key areas to consider when funding an IRA.
Laser focus has led to high performance for Gold-rated FMI Common Stock.
Both Bristol-Myers Squibb and Pfizer are well-positioned for growth.
This week on the podcast, our experts offer their mutual fund and ETF ideas for funding an IRA.
These stocks stand to benefit from higher infrastructure spending in the years to come.
Watch: For International Women's Day 2019, we look at the progress being made on gender diversity on corporate boards.
Here are two of our favorite index-tracking municipal-bond funds.